Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02047 is a long intergenic non-protein coding RNA gene in the human genome. LincRNAs, including LINC02047, are transcripts longer than 200 nucleotides that do not overlap with annotated protein-coding genes[1][3]. These molecules play roles in regulating gene expression, such as remodeling chromatin, stabilizing RNA, and functioning as enhancers or repressors at transcriptional and epigenetic levels[3][5]. While some lincRNAs are implicated in diseases, there is currently no evidence that LINC02047 itself serves as a drug target, biomarker, or has direct associations with specific diseases based on available gene and functional annotation databases[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2047 (LINC02047).